BRAMESTON Tablet Ref.[28179] Active ingredients: Bromocriptine

Source: Υπουργείο Υγείας (CY)  Revision Year: 2016  Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3508 Limassol, Cyprus

Product name and form

Brameston 2.5 mg tablets.

Pharmaceutical Form

Tablet.

White, round, flat, scored tablets.

The tablet can be divided into equal doses.

Qualitative and quantitative composition

Each tablet contains bromocriptine mesilate equivalent to 2.5 mg bromocriptine.

Excipient(s) with known effect:

This product contains 80 mg lactose.

For full list of excipients refer to point 6.1.

Active Ingredient Description
Bromocriptine

Bromocriptine is an inhibitor of prolactin secretion and a stimulator of dopamine receptors. The areas of application of bromocriptine are divided into endocrinological and neurological indications.

List of Excipients

Microcrystalline cellulose
Lactose anhydrous
Sodium starch glycolate
Colloidal silicon dioxide
Magnesium stearate
Maleic acid

Pack sizes and marketing

PVC/Aluminium blisters. Pack-sizes of 30 and 1000 tablets.

PP containers with PE closure. Pack-size of 1000 tablets.

Not all pack-sizes may be marketed.

Marketing authorization holder

Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3508 Limassol, Cyprus

Marketing authorization dates and numbers

9125

Date of first authorization: 21 October 1983
Date of latest renewal: 02 February 2009

Drugs

Drug Countries
BRAMESTON Cyprus, Malta, Singapore

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.